“Receptor”的搜索结果，显示 151-160 项，共有 3157 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... receptor positive bronchial neuroendocrine tumors that have spread to other places in the body (advanced). Radioactive drugs, such as lutetium Lu 177 ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   A Study of Cell, Serum, and Bone Marrow Bank for Patients receiving Chimeric Antigen Receptor T Cell Therapy for the Treatment of Cancer. Rochester, Minn ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   A Study of Cell, Serum, and Bone Marrow Bank for Patients receiving Chimeric Antigen Receptor T Cell Therapy for the Treatment of Cancer. Rochester, Minn ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell ...